Tablet-in-Softgel Manufacturing for Advanced Supplement Formulations

Combine liquid oils and high-dose tablet actives in a single softgel capsule to create premium joint health, longevity, sports nutrition, and beauty supplements.

Custom Tablet-in-Softgel Manufacturing

✔ Custom Formulation — From concept to commercial batch with full ingredient compatibility evaluation

✔ OEM/ODM Manufacturing — Integrated tablet core + softgel production under one platform

✔ Stability Validation — Accelerated and real-time stability testing with ICH-compliant protocols

✔ Global Regulatory Support — FDA, EU, TGA, and international market compliance documentation

What Is a Tablet-in-Softgel Capsule?

A tablet-in-softgel capsule is a hybrid dosage form that places a compressed tablet inside a liquid-filled softgel shell. This structure allows oil-based ingredients and high-dose solid actives to coexist within a single supplement unit while remaining physically separated.

Common alternative industry terms include:

• Tablet in Softgel Capsule
• Tablet Filled Softgel
• Tablet Inside Softgel
• Hybrid Softgel Delivery System
• Liquid + Tablet Combination Capsule
• Softgel with Embedded Tablet
• Multi-Phase Softgel Dosage Form

This technology is also known commercially as Unigel™ technology in the pharmaceutical industry, where tablets, granules, pellets, or capsules are filled into a large soft gelatin capsule to combine active ingredients with different release profiles or chemical incompatibility problems.citeweb_search:8#10

Why Modern Supplements Require Hybrid Delivery

The global dietary supplements market reached USD 209.5 billion in 2025 and is projected to grow to USD 431.7 billion by 2033, expanding at a CAGR of 9.5% (Grand View Research, 2026). Consumers are no longer satisfied with single-ingredient products. They demand Longevity Stacks, Joint Complexes, Sports Performance Formulas, and Beauty Supplements that combine multiple actives with different physicochemical properties.

According to the World Health Organization (WHO), over 2 billion people worldwide suffer from micronutrient deficiencies (WHO, 2023). More than 30% of millennials now prefer supplements tailored to their unique health concerns (Grand View Research, 2026). This shift has created a critical manufacturing challenge: how to combine liquid ingredients (oils, lipid-soluble vitamins), powder ingredients (minerals, botanical extracts), and different release profiles within a single dosage form without compromising stability, efficacy, or consumer compliance.

Tablet-in-Softgel technology solves this by embedding a compressed tablet core inside a liquid-filled softgel—delivering multiple ingredient types in one serving, reducing pill burden by 50-80%, and creating differentiated premium products that command higher margins.

Why KS Nutripharma for Tablet-in-Softgel Manufacturing

Integrated Tablet + Softgel Production

Develop both tablet cores and liquid softgel systems under one manufacturing platform. No outsourcing between tablet and softgel phases means faster development timelines, lower coordination costs, and single-point accountability for quality.

Advanced Compatibility Evaluation

Assess tablet-liquid interactions, oxidation risks, moisture migration, and stability before commercial production. Our pre-formulation screening identifies incompatibilities at the pilot stage—preventing costly failures at scale.

Flexible Formula Development

Support omega oils, CoQ10, curcumin, glucosamine, minerals, botanical extracts, longevity ingredients, and custom ingredient combinations. From standard formulations to first-to-market concepts.

Large-Scale Manufacturing Capacity

Global OEM/ODM Experience

Supporting supplement brands across North America, Europe, Asia-Pacific, and emerging markets with full export documentation, regulatory dossiers, and market-specific labeling compliance.

Intellectual Property Protection

We understand that innovative formulations are valuable business assets.

KS Nutripharma supports:

• Formula Confidentiality Agreements— NDAs signed before any formulation disclosure
• Restricted-Access Development Workflows— Dedicated project teams with compartmentalized access
• Controlled Document Management— Secure file sharing with audit trails and version control
• Exclusive Manufacturing Arrangements— First-right-of-refusal for proprietary formulations
• Long-Term Supply Continuity Planning— Multi-year supply agreements with locked pricing

For brands developing proprietary formulations, ingredient combinations, or market-first concepts, IP protection is integrated throughout the OEM/ODM process.

Tablet-in-Softgel Manufacturing Capabilities

Tablet Core Capabilities

Liquid Fill Capabilities

Shell Systems

The global vegetarian softgel capsules market is valued at USD 13.19 billion in 2025 and projected to reach USD 30.18 billion by 2032 at a CAGR of 12.54% (360iResearch, 2026). Over 68% of supplement consumers now prefer non-animal capsule formulations (Business Research Insights, 2026).citeweb_search:8#15

Packaging Options

• Bottles: HDPE, PET, glass (30ct–300ct); child-resistant caps available
• Blisters: PVC, aluminum, cold-form foil; single-dose or multi-dose
• Retail Boxes: Custom design with regulatory-compliant labeling
• Sachets/Stick Packs: Single-serve powder or liquid; travel-friendly
• Bulk: Cartons with pallet for repackaging or further processing

Who Uses Tablet-in-Softgel Technology?

Tablet-in-Softgel systems are commonly developed for:

Supplement Brands

Launch differentiated premium products that stand out on shelf and online. The visible tablet inside the softgel creates instant consumer recognition of advanced formulation.

Longevity Brands

Combine mitochondrial support ingredients (CoQ10, PQQ in liquid phase) with cellular renewal actives (Urolithin A, Spermidine in tablet phase) in one convenient daily dose.

Sports Nutrition Companies

Integrate oils (MCT, omega-3 for energy and recovery) with high-dose solid ingredients (electrolytes, amino acids, tart cherry) for performance and post-workout formulas.

Beauty Supplement Brands

Combine lipid-based beauty actives (ceramides, astaxanthin, vitamin E) with structural nutrients (collagen peptides, hyaluronic acid, zinc) for inside-out beauty positioning.

Pharmaceutical & Nutraceutical Developers

Improve ingredient compatibility and dosage convenience for fixed-dose combination products. The physical separation solves chemical incompatibility problems that would otherwise require separate products.citeweb_search:8#10

How Tablet-in-Softgel Technology Works

Step 1: Tablet Core Manufacturing

• Dimension Control: Tablet diameter and thickness precisely controlled to fit within the softgel cavity (±0.05mm tolerance)
• Friability: Optimized hardness to withstand encapsulation without chipping (target: 4-8 kp)
• Core Ingredients: Minerals, botanical extracts, sustained-release matrices, high-dose amino sugars
• Release Design: Immediate-release, sustained-release, or enteric-coated tablet cores available

Step 2: Liquid Fill Preparation

• Fill Materials: Omega-3 oils, CoQ10 suspensions, curcumin oil extracts, MCT oil, lipid-based vitamins
• Stability: Fill must not migrate into tablet core or degrade shell integrity
• Antioxidant System: Mixed tocopherols, rosemary extract, or ascorbyl palmitate for oil stability
• SEDDS Compatibility: Self-emulsifying systems for enhanced bioavailability of poorly soluble actives

Step 3: Precision Tablet Placement

• Positioning: Tablet centered within softgel die with <0.2mm deviation
• Protection: Mechanical stress minimized during encapsulation
• Orientation: Correct alignment to prevent contact with sealing zone
• Vision Verification: Automated inspection rejects off-center or misaligned units

Step 4: Softgel Encapsulation

• Process: Rotary die encapsulation with tablet suspended in liquid fill
• Speed: Commercial lines run at 150,000–500,000 units/hour
• Result: Liquid + Tablet Hybrid System in single dosage unit
• Drying: Tumble drying + controlled tunnel drying (24-72 hours) to achieve target shell moisture

Technical Challenges We Solve

High-Dose Tablet Loading

Support larger tablet cores (up to 1000mg) while maintaining softgel shell integrity. Our compression profiles optimize tablet density for softgel compatibility without compromising disintegration time.

Oxidation-Sensitive Formulations

Separate reactive minerals (iron, copper) from omega oils and lipid-based actives. The tablet core acts as a physical barrier, preventing catalytic oxidation of high-value liquid ingredients.

Tablet Positioning Accuracy

Maintain precise tablet placement to ensure consistent shell thickness and appearance. Automated vision systems verify every unit—rejecting off-center or misaligned products before packaging.

Hybrid Stability Management

Optimize compatibility between tablet, liquid fill, and shell materials. Our 4-week accelerated compatibility screening (40°C/75% RH) identifies issues before commercial scale-up.

Sustained & Delayed Release Design

The tablet core can be designed with immediate-release, sustained-release, or enteric-release characteristics while the liquid phase remains immediately available. This enables dual-phase delivery where ingredients release at different times or in different gastrointestinal segments.

Multi-Ingredient Formulation Strategies

Oil + Mineral Systems

Lipid + Botanical Systems

Beauty Formulations

Longevity Formulations

The longevity market is valued at approximately USD 29 billion in 2026 with a CAGR of 8%, with supplements representing 42% of total revenue (NewMarketPitch, 2025). The NAD+ market alone is USD 3.45 billion, with CoQ10 at USD 700 million, resveratrol at USD 200 million, and spermidine at USD 175 million.

Tablet-in-Softgel technology enables separation of lipid-soluble mitochondrial ingredients from moisture-sensitive longevity actives, helping brands develop premium healthy aging formulations with extended shelf life and superior stability.

Why Longevity Brands Are Adopting Tablet-in-Softgel

Many longevity ingredients have very different stability requirements:

• Lipid-phase ingredients(CoQ10, PQQ, astaxanthin, omega-3) are oil-soluble and require antioxidant protection
• Tablet-phase ingredients(Urolithin A, spermidine, NMN, resveratrol) are moisture-sensitive and degrade when exposed to liquid environments

Tablet-in-Softgel technology physically separates these incompatible ingredient classes while reducing capsule burden for consumers who may already be taking 5-10+ supplements daily. This addresses the #1 consumer complaint in the longevity category: too many pills.

Examples of Tablet-in-Softgel Formulations

Triple-Action Joint Support

Liquid Phase: – Omega-3 fatty acids (EPA 500mg + DHA 250mg) – Curcumin oil extract (95% curcuminoids, 100mg) – Vitamin E (mixed tocopherols, 15mg)

Tablet Phase: – Glucosamine sulfate (750mg) – Chondroitin sulfate (400mg) – MSM (200mg) – Boswellia extract (100mg)

Result: One unit replaces 3–4 separate products. The bone and joint health market is growing at 6.41% CAGR and is expected to reach USD 19.24 billion by 2031 (Mordor Intelligence, 2026).

Mitochondrial Longevity Formula

Liquid Phase: – CoQ10 (100mg) – PQQ (20mg) – Omega-3 (EPA/DHA 500mg)

Tablet Phase: – Urolithin A (500mg) – Spermidine (10mg) – Resveratrol (250mg)

Result: Separates lipid-soluble mitochondrial support from moisture-sensitive autophagy activators.

Beauty From Within Formula

Liquid Phase: – Ceramides (30mg) – Vitamin E (15mg) – Astaxanthin (6mg)

Tablet Phase: – Hyaluronic Acid (120mg) – Collagen Tripeptide (100mg) – Zinc (15mg) – Biotin (5000mcg)

Result: Combines lipid-based skin barrier support with water-soluble structural proteins in one premium unit.

Sports Recovery Formula

Liquid Phase: – MCT Oil (1000mg) – Omega-3 (500mg) – Astaxanthin (6mg)

Tablet Phase: – Leucine (500mg) – Electrolyte Blend (Sodium, Potassium, Magnesium — 300mg) – Tart Cherry Extract (500mg)

Result: The sports nutrition market is valued at USD 31.53 billion in 2025 and projected to reach USD 55.63 billion by 2032 at 8.44% CAGR (360iResearch, 2026).

Tablet-in-Softgel vs. Related Technologies: Procurement Guide

Tablet-in-Softgel vs. Standard Softgel

Tablet-in-Softgel vs. Capsule-in-Capsule

Tablet-in-Softgel vs. Multi-Fill Softgel

Tablet-in-Softgel vs. Softgel-in-Softgel

Recommendation: Choose Tablet-in-Softgel when your formulation requires significant liquid lipid content combined with high-dose solid actives (joint health, cardiovascular, beauty). Choose Capsule-in-Capsule when precise release timing or enteric protection is critical (probiotics, acid-sensitive ingredients). Choose Multi-Fill Softgel for multiple oil-based ingredients without solid components. Choose Softgel-in-Softgel for complex liquid-liquid separation with different release profiles.

Quality & Compliance

Tablet-in-Softgel products are manufactured under cGMP-compliant systems with:

• Raw Material Verification— Identity testing for all incoming ingredients per FDA 21 CFR Part 111
• Tablet Core Testing— Hardness, friability, disintegration, content uniformity
• Fill Weight Control— In-process check weighing every 15 minutes (CV <3.0%)
• Shell Integrity Testing— Visual inspection, dye penetration, seam strength
• Dissolution Verification— USP <711> two-tier approach for cross-linking detection
• Stability Validation— ICH Q1A(R2) accelerated (40°C/75% RH, 6 months) and long-term (25°C/60% RH, 24+ months)

Supporting FDA, EU, TGA, and international supplement markets.

OEM & ODM Development Process

Phase 1: Formula Evaluation (2–4 weeks)
├ Ingredient compatibility screening
├ Dose feasibility analysis
├ Regulatory pathway assessment
└Cost modeling

Phase 2: Compatibility Study (2–3 weeks)
├  4-week accelerated compatibility (40°C/75% RH)
├  Physical observation
├  Chemical assay
└  Microbial screening

Phase 3: Tablet Design (2–3 weeks)
├ Compression profile optimization
├Disintegration time targeting
├ Hardness/friability balance
└ Dimension verification for softgel fit

Phase 4: Liquid Phase Development (2–3 weeks)
├ Fill formulation (oil selection, antioxidant system)
├ Viscosity optimization
├ Stability baseline
└ Taste evaluation (if applicable)

Phase 5: Prototype Manufacturing (1–2 weeks)
├ Pilot batch (1,000–5,000 units)
├ In-process testing
├Visual inspection
└ Initial dissolution sampling

Phase 6: Stability Testing (12–24 weeks)
├ Accelerated stability (6 months)
├Real-time stability (ongoing)
├ Microbial limits
└Packaging compatibility

Phase 7: Commercial Production
├ Process validation (3 batches)
├ Scale-up qualification
├ Commercial release testing
└ Ongoing stability monitoring

Total Development Timeline: 12–24 weeks from concept to first commercial batch (depending on complexity and stability requirements)

Frequently Asked Questions

What is the typical MOQ for Tablet-in-Softgel manufacturing?

MOQ depends on formulation complexity, softgel size, and packaging requirements. Standard Tablet-in-Softgel projects typically start at 100,000–300,000 units for custom formulations. For simpler formulations or shared production runs, lower MOQs may be evaluated on a case-by-case basis. Contact our team for a custom evaluation based on your specific formula.

Can custom tablet cores be developed?

Yes. We develop custom tablet cores from scratch—including compression profile optimization, disintegration time targeting, and dimension verification for softgel compatibility. Tablet weights range from 50mg to 1000mg, with diameters from 4mm to 10mm to fit standard softgel sizes. Immediate-release, sustained-release, and enteric-coated tablet cores are all available.

Can you combine omega oils with glucosamine tablets?

Yes. This is one of our most requested combinations. Omega-3 oils are placed in the liquid fill, while glucosamine, chondroitin, and MSM are compressed into the tablet core. The physical separation prevents moisture migration from the tablet to the oil, protecting omega-3 stability while delivering both actives in one unit.

What is the development timeline?

Standard timeline is 12–24 weeks from concept to first commercial batch: – Formula evaluation: 2–4 weeks – Compatibility + tablet design: 4–6 weeks – Prototype manufacturing: 1–2 weeks – Stability testing: 12–24 weeks (can run parallel with other activities) – Process validation + commercial release: 2–4 weeks

Complex formulations or novel ingredients may extend this timeline.

Can Tablet-in-Softgel products be vegetarian?

Yes. We offer vegetarian shell options using HPMC, carrageenan, pea starch, or pullulan. The global vegetarian softgel market is growing at 12.54% CAGR (360iResearch, 2026), and over 68% of consumers now prefer plant-based capsules. Note that some vegetarian shells have different moisture barrier properties compared to gelatin—our compatibility evaluation addresses this during development.

Which international markets can be supported?

We support regulatory compliance for North America (FDA), European Union (EFSA), Australia (TGA), Canada (Health Canada), and emerging markets across Asia-Pacific, Latin America, and the Middle East. Full export documentation, COA, and regulatory dossiers are provided.

Can you assist with formulation optimization?

Yes. Our R&D team provides: – Ingredient selection guidance based on stability, bioavailability, and regulatory status – Dose optimization to maximize active loading per unit – Cost engineering to meet target price points without compromising quality – Competitive analysis of existing products in your target category

What packaging options are available?

• Bottles: HDPE, PET, glass (30ct–300ct); child-resistant caps available
• Blisters: PVC, aluminum, cold-form foil; single-dose or multi-dose
• Sachets/Stick Packs: Single-serve; travel-friendly
• Retail Boxes: Custom design with regulatory-compliant labeling
• Bulk: Cartons with pallet for repackaging

How does Tablet-in-Softgel compare with standard softgel in cost?

Tablet-in-Softgel typically costs 20–40% more per unit than standard softgel due to: – Additional tablet manufacturing step – Precision tablet placement equipment – Dual-phase quality control – Lower production speed compared to standard softgel

However, the premium positioning supports 30–50% higher retail price points, and the reduced pill count improves consumer compliance and repeat purchase rates.

Is this technology suitable for sports nutrition products?

Yes. The sports nutrition market (USD 31.53B, 8.44% CAGR) is increasingly adopting hybrid delivery. Common combinations include MCT oil + BCAAs (recovery), CoQ10 + creatine (performance), and omega-3 + electrolytes (endurance). The tablet core can deliver high-dose solids while the liquid phase provides lipid-based energy substrates.

Can Tablet-in-Softgel support sustained or delayed release?

Yes. The tablet core can be designed with immediate-release, sustained-release, or enteric-release characteristics while the liquid phase remains immediately available. This enables dual-phase delivery where ingredients release at different times or in different gastrointestinal segments—creating differentiated functional benefits for your product.

What ingredients are not suitable for Tablet-in-Softgel?

Extremely moisture-sensitive powders, highly hygroscopic materials, or ingredients requiring very large tablet volumes may require alternative delivery technologies such as Capsule-in-Capsule systems. During the formula evaluation phase, we assess each ingredient’s suitability and recommend the optimal delivery system.

What is the typical shelf life?

Standard shelf life is 24–36 months from date of manufacture, established through ICH-compliant stability studies. Actual shelf life depends on ingredient stability, shell material, antioxidant system, and packaging configuration. We provide shelf-life validation as part of the development process.

What is the lead time for commercial orders?

Once the formulation is validated and stability data is established, commercial production lead time is typically 4–8 weeks depending on: – Raw material availability and lead times – Production schedule and capacity allocation – Packaging material procurement – Regulatory documentation preparation

Repeat orders for established formulations typically have shorter lead times (2–4 weeks).

Who owns the formula?

Formula ownership is defined in the OEM/ODM agreement. Options include: – Customer-owned formula: You retain full IP rights; we manufacture under confidentiality – Co-developed formula: Joint IP with exclusive manufacturing rights for KS Nutripharma – KS-developed formula: We license the formulation to you for exclusive or non-exclusive use

All arrangements are documented in formal agreements with NDA protection.

Develop Advanced Tablet-in-Softgel Supplements with KS Nutripharma

Create premium hybrid supplement products that combine liquid and solid active ingredients within a single dosage form. Our integrated formulation and manufacturing platform supports custom Tablet-in-Softgel development for:

• Joint Health— Omega-3 + Glucosamine/Chondroitin combinations
• Sports Nutrition— MCT Oil + Recovery Complex, CoQ10 + Performance Ingredients
• Healthy Aging— CoQ10/PQQ + Urolithin A/Spermidine
• Beauty Supplements— Ceramides + Collagen/Hyaluronic Acid
• Immune Support— Lipid-soluble vitamins + mineral/botanical complexes
• Custom Applications— Your formulation concept, our manufacturing expertise

Request a Custom Formulation Quote →

Related Technology & Application Pages

Technology Cluster

• /capsule-in-capsule-technology— Multi-capsule systems for controlled release
• /softgel-in-softgel-technology— Nested softgel for ingredient separation
• /multi-fill-softgel-technology— Multiple liquid fills in one softgel
• /enteric-coated-softgel— Intestinal release protection
• /tablet-in-softgel-vs-standard-softgel— Direct comparison for procurement

Application Cluster

• /joint-support-softgel-formulas— Formulation guidance for joint health
• /longevity-supplement-formulations— Anti-aging and cellular health
• /sports-nutrition-softgel-formulas— Performance and recovery
• /beauty-softgel-formulas— Nutricosmetic applications

Ingredient Cluster

• /urolithin-a-supplement— Mitochondrial health ingredient
• /spermidine-supplement— Autophagy and cellular renewal
• /coq10-softgel— Cellular energy production
• /omega-3-softgel— Essential fatty acid delivery
• /nmn-supplement— NAD+ precursor
• /resveratrol-supplement— Sirtuin activation

Quality & Compliance

• /supplement-stability-testing— ICH-compliant stability protocols
• /supplement-quality-control— cGMP testing and validation

References & Data Sources

1. Grand View Research. (2026). Dietary Supplements Market Report 2026-2033. https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market-report
2. Mordor Intelligence. (2026). Bone And Joint Health Supplements Market Size and Share. https://www.mordorintelligence.com/industry-reports/global-bone-and-joint-health-supplements-market
3. SNS Insider. (2026). Softgel Capsule Market Size, Growth and Trends Report 2026-2035. https://www.snsinsider.com/reports/softgel-capsule-market-1183
4. (2026). Sports Nutrition & Supplement Market Size & Share 2026-2032. https://www.360iresearch.com/library/intelligence/sports-nutrition-supplement
5. (2026). Vegetarian Softgel Capsules Market Size & Share 2026-2032. https://www.360iresearch.com/library/intelligence/vegetarian-softgel-capsules
6. (2025). Longevity Market Size 2026: $29 B | CAGR 8%. https://newmarketpitch.com/blogs/news/longevity-market-size
7. Business Research Insights. (2026). Top 10 Companies in Vegetarian Softgel Capsules Market. https://www.businessresearchinsights.com/blog/top-vegetarian-softgel-capsules-companies-10634
8. (2023). Micronutrient Deficiencies. https://www.who.int/health-topics/micronutrients
9. S. FDA. (2007). Current Good Manufacturing Practice (21 CFR Part 111). https://www.govinfo.gov/content/pkg/FR-2007-06-25/pdf/07-3039.pdf
10. (2024). USP <711> Dissolution. https://www.uspnf.com
11. (2003). Q1A(R2) Stability Testing of New Drug Substances and Products.
12. (2024). The Development of Innovative Dosage Forms of the Fixed-Dose Combination. https://pdfs.semanticscholar.org/3940/847207c73a9fcf25273348e15361c829686b.pdf
13. Research and Markets. (2026). Vegetarian Softgel Capsules Market Size & Forecast to 2032. https://www.researchandmarkets.com/report/vegetarian-softgel-capsules
14. CSK Biotech. (2025). Top 10 Softgel Supplement Manufacturers & Supplier Brands. https://www.cskbiotech.com/article/top-softgel-supplement-manufacturers/
15. Collagen SEI. (2025). Softgel Supplements Comprehensive Guide 2025. https://collagensei.com/softgel-supplements-comprehensive-guide/

Last Updated: June 2026 This page is intended for B2B procurement and brand development professionals. All market data is sourced from publicly available industry reports. Manufacturing capabilities and timelines are representative—contact our team for project-specific evaluation.